Analysis: why the Supreme Court overturned two patent specialists
Mr Justice Kitchin and Lord Justice Jacob were clear that HGS’s patent for the Neutrokine-a protein was invalid for lacking industrial application. But five Supreme Court judges today disagreed. Why?
The five judges unanimously ruled that Article 57 of the EPC does not require patent applications for new genes to provide evidence of clinical tests to show industrial application.
Article 57 says that an invention is susceptible of industrial application...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.